ARLINGTON, Va., July 19, 2017 — The members of the American Society for Radiation Oncology (ASTRO) have elected three new officers to ASTRO's Board of Directors and three members to serve on the medical society's Nominating Committee. The newly elected President-elect, Health Policy Council Vice-chair, Science Council Vice-chair and Nominating Committee members will begin their terms at the Annual Business Meeting held during ASTRO's 59th Annual Meeting in San Diego, September 24-27.

The following radiation oncologists were elected to the Board of Directors:

President-elect: Theodore L. DeWeese, MD, FASTRO, Johns Hopkins Medicine, Baltimore
Health Policy Council Vice-chair: William Hartsell, MD, FASTRO, Northwestern Medicine, Chicago Proton Center, Chicago
Science Council Vice-chair: Catherine Park, MD, University of California, San Francisco
The following physicians and scientists were elected to the Nominating Committee:

Nominating Committee Academic Physician: Charles Thomas, MD, Oregon Health and Science University, Portland, Oregon
Nominating Committee Community Practice Physician: Paul Sperduto, MD, MPP, FASTRO, Minneapolis Radiation Oncology PA, Minneapolis
Nominating Committee Radiobiologist: Jacqueline P. Williams, PhD, FASTRO, University of Rochester Medical Center, Rochester, New York

"The cancer care community is undergoing a seismic shift, as we determine what the next chapter will be. Radiation oncology is a key part of many of these discussions—from immunotherapy combinations to health care reform. These demonstrated leaders will help guide the 10,000-plus ASTRO members and our field on key issues of science, health policy and patient care," said David C. Beyer, MD, FASTRO, Chair of ASTRO's Board of Directors.

Dr. Theodore L. DeWeese (President-elect) is Vice President for Johns Hopkins Medicine and the Sidney Kimmel Professor and Chair of the department of radiation oncology and molecular radiation sciences at Johns Hopkins University, where he treats men with prostate cancer. He is a funded laboratory researcher and also leads therapeutic and non-therapeutic clinical trials for men with prostate cancer. He is an advisory board member of several prominent cancer centers and the Chair of the ASTRO Science Council.

Dr. DeWeese is dedicated to actively promoting the central role of radiation oncology in the cancer care continuum. He has established partnerships with other medical societies and collaborative funding opportunities to grow the pipeline of young cancer researchers. He also helped build scientific programs at annual meetings for the nation's leading cancer societies, as Chair of the ASTRO Annual Meeting Scientific Committee for three years and as a member of the planning committees for the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) meetings.

Business Affairs Homepage